GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Dissolved Manchester

Other research and experimental development on natural sciences and engineering

Life sciences and medical technology Other research and experimental development on natural sciences and engineering
G

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Other research and experimental development on natural sciences and engineering

Founded 6 Mar 2001 Dissolved Manchester, United Kingdom website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering

Previous Company Names

CARETEK MEDICAL LIMITED 23 Aug 2001 — 7 Sept 2006
MC182 LIMITED 6 Mar 2001 — 23 Aug 2001
Accounts
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges 4
1 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

Rsm Restructuring Advisory Llp 3 Hardman Street Manchester M3 3HF

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789), a dissolved life sciences and medical technology company based in Manchester, United Kingdom. Incorporated 6 Mar 2001. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 252,950 Shares £253k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Jan 2017213,850£214k£214k
19 Jan 201739,100£39k£39k

Officers

Officers

1 active 2 resigned
Status
Ian Joseph SmithDirectorBritishUnited Kingdom7814 Dec 2011Active

Shareholders

Shareholders (127)

Bank Of New York (nominees) Limited (invesco Pep Income Fund)
18.7%
1,884,329
Bank Of New York (nominees) Ltd (invesco Pep High Income Fund)
18.7%
1,884,329

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Anthony Rowlands

British

Active
Notified 20 Jan 2017
Residence Monaco
DOB June 1956
Nature of Control
  • Significant Influence Or Control
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED Current Company

Charges

Charges

1 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Oct 2018GazetteGazette Dissolved Liquidation
20 Jul 2018InsolvencyLiquidation In Administration Move To Dissolution
3 Jul 2018InsolvencyLiquidation In Administration Resignation Of Administrator
3 Jul 2018InsolvencyLiquidation In Administration Appointment Of Administrator
15 Mar 2018InsolvencyLiquidation In Administration Progress Report
20 Oct 2018 Gazette

Gazette Dissolved Liquidation

20 Jul 2018 Insolvency

Liquidation In Administration Move To Dissolution

3 Jul 2018 Insolvency

Liquidation In Administration Resignation Of Administrator

3 Jul 2018 Insolvency

Liquidation In Administration Appointment Of Administrator

15 Mar 2018 Insolvency

Liquidation In Administration Progress Report

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

7 years ago on 20 Oct 2018

Liquidation In Administration Move To Dissolution

7 years ago on 20 Jul 2018

Liquidation In Administration Resignation Of Administrator

7 years ago on 3 Jul 2018

Liquidation In Administration Appointment Of Administrator

7 years ago on 3 Jul 2018

Liquidation In Administration Progress Report

8 years ago on 15 Mar 2018